rheumatology
Psoriatic arthritis

Hopes dashed for bDMARD register

A push to track patients switching between originator biologics and their biosimilars through a national database has hit a brick wall, after the federal government dismissed the need for it. The Australian Rheumatology Association says a national database of prescribing and dispensing data for inflammatory arthritis patients is needed to monitor the safety and efficacy ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic